Open-Label Study of Duloxetine in the Treatment of Children and Adolescents With Major Depressive Disorder
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The primary purpose of your participation in this study is to help answer the following
research question, and not to provide you treatment for your condition. Whether duloxetine
once daily orally is tolerated and safe, in children (aged 7 through 11 years) and
adolescents (aged 12 through 17 years) with Major Depressive Disorder.